Patents by Inventor Kayanat Mahammadtaki Gani

Kayanat Mahammadtaki Gani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11697672
    Abstract: The present invention relates to a purification process of recombinant antibody fragments from inclusion bodies expressed in microbial cells. More particularly, the present invention relates to a process for purification of recombinant humanized (rHu) antibody fragment, Ranibizumab from inclusion bodies expressed in microbial cells.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: July 11, 2023
    Assignee: Council of Scientific & Industrial Research
    Inventors: Rahul Sharad Bhambure, Kayanat Mahammadtaki Gani
  • Patent number: 11524996
    Abstract: The present invention relates to a novel cloning, expression and refolding process for preparing antibody fragments. More particularly, the present invention relates to a cloning, expression and refolding platform for preparing recombinant humanized (rHu) Ranibizumab.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: December 13, 2022
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Rahul Sharad Bhambure, Kayanat Mahammadtaki Gani
  • Publication number: 20200140535
    Abstract: The present invention relates to a novel cloning, expression and refolding process for preparing antibody fragments. More particularly, the present invention relates to a cloning, expression and refolding platform for preparing recombinant humanized (rHu) Ranibizumab.
    Type: Application
    Filed: November 15, 2019
    Publication date: May 7, 2020
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Rahul Sharad BHAMBURE, Kayanat Mahammadtaki GANI
  • Publication number: 20200095277
    Abstract: The present invention relates to a purification process of recombinant antibody fragments from inclusion bodies expressed in microbial cells. More particularly, the present invention relates to a process for purification of recombinant humanized (rHu) antibody fragment, Ranibizumab from inclusion bodies expressed in microbial cells.
    Type: Application
    Filed: March 23, 2018
    Publication date: March 26, 2020
    Inventors: Rahul Sharad Bhambure, Kayanat Mahammadtaki Gani